{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T18:10:01Z","timestamp":1745691001410,"version":"3.40.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Nielsen BioSciences, Inc"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s13555-025-01387-1","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T02:01:19Z","timestamp":1744077679000},"page":"1135-1152","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Randomized Phase\u00a0IIa Trial of Purified Candida Antigen for Common Warts: Evaluating the Safety and Efficacy Across Multiple Dosing Regimens"],"prefix":"10.1007","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct02393417","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Stacy R.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"Esch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. S.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra Marchese","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,29]]},"reference":[{"issue":"24","key":"1387_CR1","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","volume":"375","author":"EL Simpson","year":"2016","unstructured":"Simpson EL, Bieber T, Guttman-Yassky E, et al. Two phase\u00a03 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med. 2016;375(24):2335\u201348.","journal-title":"N Engl J Med"},{"key":"1387_CR2","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.2147\/CCID.S415019","volume":"16","author":"JH Liu","year":"2023","unstructured":"Liu JH, Gao Q, Ma WY, Cheng ZL, Luo NN, Hao PS. Successful treatment of psoriasis combined with bullous pemphigoid with dupilumab: a case report. Clin Cosmet Investig Dermatol. 2023;16:1583\u20137.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"4","key":"1387_CR3","first-page":"484","volume":"21","author":"H Gan","year":"2022","unstructured":"Gan H, Gao YD. Occupational chronic hand dermatitis in hospital environment successfully treated with dupilumab: a case report. Iran J Allergy Asthma Immunol. 2022;21(4):484\u20137.","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"6","key":"1387_CR4","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1111\/jocd.12472","volume":"17","author":"MA El-Hamd","year":"2018","unstructured":"El-Hamd MA, Assaf HA, Nada EA. Possible role of interleukin-17 and macrophage migration inhibitory factor in cutaneous warts. J Cosmet Dermatol. 2018;17(6):1250\u20133.","journal-title":"J Cosmet Dermatol"},{"issue":"3","key":"1387_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/dth.12352","volume":"29","author":"AS Aldahan","year":"2016","unstructured":"Aldahan AS, Mlacker S, Shah VV, et al. Efficacy of intralesional immunotherapy for the treatment of warts: a review of the literature. Dermatol Ther. 2016;29(3):197\u2013207.","journal-title":"Dermatol Ther"},{"issue":"1","key":"1387_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/1941738118789954","volume":"11","author":"AR Peterson","year":"2019","unstructured":"Peterson AR, Nash E, Anderson BJ. Infectious disease in contact sports. Sports Health. 2019;11(1):47\u201358.","journal-title":"Sports Health"},{"issue":"2","key":"1387_CR7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.7556\/jaoa.2018.024","volume":"118","author":"DJ Witchey","year":"2018","unstructured":"Witchey DJ, Witchey NB, Roth-Kauffman MM, Kauffman MK. Plantar warts: epidemiology, pathophysiology, and clinical management. J Am Osteopath Assoc. 2018;118(2):92\u2013105.","journal-title":"J Am Osteopath Assoc"},{"issue":"12","key":"1387_CR8","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1038\/jid.2013.226","volume":"133","author":"JI Silverberg","year":"2013","unstructured":"Silverberg JI, Silverberg NB. The U.S. prevalence of common warts in childhood: a population-based study. J Invest Dermatol. 2013;133(12):2788\u201390.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"1387_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/1203475415616962","volume":"20","author":"AK Dhakar","year":"2016","unstructured":"Dhakar AK, Dogra S, Vinay K, Sarangal R, Kanwar AJ, Singh MP. Intralesional mycobacterium w vaccine versus cryotherapy in treatment of refractory extragenital warts: a randomized, open-label, comparative study. J Cutan Med Surg. 2016;20(2):123\u20139.","journal-title":"J Cutan Med Surg"},{"issue":"4","key":"1387_CR10","first-page":"44","volume":"15","author":"MQH Leow","year":"2016","unstructured":"Leow MQH, Oon HHB. The impact of viral warts on the quality of life of patients. Dermatol Nurs. 2016;15(4):44\u20138.","journal-title":"Dermatol Nurs"},{"issue":"3","key":"1387_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1046\/j.1440-0960.2003.00672.x","volume":"44","author":"A Ciconte","year":"2003","unstructured":"Ciconte A, Campbell J, Tabrizi S, Garland S, Marks R. Warts are not merely blemishes on the skin: a study on the morbidity associated with having viral cutaneous warts. Australas J Dermatol. 2003;44(3):169\u201373.","journal-title":"Australas J Dermatol"},{"issue":"6","key":"1387_CR12","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1111\/jocd.14468","volume":"21","author":"M Abu El-Hamd","year":"2022","unstructured":"Abu El-Hamd M, Aboeldahab S. A case of resistant multiple plantar warts cured with combined autologous platelet-rich plasma injection and topical salicylic acid 30. J Cosmet Dermatol. 2022;21(6):2417\u20139.","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"1387_CR13","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/jocd.12805","volume":"18","author":"AM Abdel Meguid","year":"2019","unstructured":"Abdel Meguid AM, Abdel Motaleb AA, Abdel Sadek AMI. Cryotherapy vs trichloroacetic acid 90% in treatment of common warts. J Cosmet Dermatol. 2019;18(2):608\u201313.","journal-title":"J Cosmet Dermatol"},{"issue":"5","key":"1387_CR14","doi-asserted-by":"publisher","first-page":"832","DOI":"10.3390\/jcm4050832","volume":"4","author":"R Kollipara","year":"2015","unstructured":"Kollipara R, Ekhlassi E, Downing C, Guidry J, Lee M, Tyring SK. Advancements in pharmacotherapy for noncancerous manifestations of HPV. J Clin Med. 2015;4(5):832\u201346.","journal-title":"J Clin Med"},{"issue":"2","key":"1387_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15240","volume":"35","author":"JW Park","year":"2022","unstructured":"Park JW, Han HS, Koh YG, Seo SB, Kim GH, Park KY. Split-face comparative trial of 785-nm picosecond neodymium:yttrium-aluminum-garnet laser and precision cryotherapy combination treatment for facial benign pigmented lesions. Dermatol Ther. 2022;35(2):e15240.","journal-title":"Dermatol Ther"},{"issue":"9","key":"1387_CR16","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1111\/j.1468-3083.2010.03906.x","volume":"25","author":"N Tomson","year":"2011","unstructured":"Tomson N, Sterling J, Ahmed I, Hague J, Berth-Jones J. Human papillomavirus typing of warts and response to cryotherapy. J Eur Acad Dermatol Venereol. 2011;25(9):1108\u201311.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"1387_CR17","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/ijd.13535","volume":"56","author":"F Khozeimeh","year":"2017","unstructured":"Khozeimeh F, Jabbari Azad F, Mahboubi Oskouei Y, et al. Intralesional immunotherapy compared to cryotherapy in the treatment of warts. Int J Dermatol. 2017;56(4):474\u20138.","journal-title":"Int J Dermatol"},{"issue":"4","key":"1387_CR18","first-page":"451","volume":"137","author":"SM Johnson","year":"2001","unstructured":"Johnson SM, Roberson PK, Horn TD. Intralesional injection of mumps or Candida skin test antigens: a novel immunotherapy for warts. Arch Dermatol. 2001;137(4):451\u20135.","journal-title":"Arch Dermatol"},{"issue":"10","key":"1387_CR19","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/ijd.13709","volume":"56","author":"A Nofal","year":"2017","unstructured":"Nofal A, Marei A, Amer A, Amen H. Significance of interferon gamma in the prediction of successful therapy of common warts by intralesional injection of Candida antigen. Int J Dermatol. 2017;56(10):1003\u20139.","journal-title":"Int J Dermatol"},{"key":"1387_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.intimp.2018.01.037","volume":"56","author":"X Wang","year":"2018","unstructured":"Wang X, Che Y, Chen B, Zhang Y, Nakagawa M, Wang X. Evaluation of immune responses induced by a novel human papillomavirus type\u00a016 E7 peptide-based vaccine with Candida skin test reagent as an adjuvant in C57BL\/6 mice. Int Immunopharmacol. 2018;56:249\u201360.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"1387_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12997","volume":"32","author":"G Fathy","year":"2019","unstructured":"Fathy G, Sharara MA, Khafagy AH. Intralesional vitamin\u00a0D3 versus Candida antigen immunotherapy in the treatment of multiple recalcitrant plantar warts: a comparative case-control study. Dermatol Ther. 2019;32(5):e12997.","journal-title":"Dermatol Ther"},{"issue":"3","key":"1387_CR22","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1177\/1203475420988859","volume":"25","author":"A Nofal","year":"2021","unstructured":"Nofal A, Alakad R, Fouda I, Fawzy MM. Intralesional antigen immunotherapy in the treatment of periungual warts. J Cutan Med Surg. 2021;25(3):286\u201392.","journal-title":"J Cutan Med Surg"},{"issue":"4","key":"1387_CR23","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.jaad.2018.07.003","volume":"80","author":"S Salman","year":"2019","unstructured":"Salman S, Ahmed MS, Ibrahim AM, et al. Intralesional immunotherapy for the treatment of warts: a network meta-analysis. J Am Acad Dermatol. 2019;80(4):922-30e4.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1387_CR24","doi-asserted-by":"publisher","first-page":"364","DOI":"10.4103\/2229-5178.190487","volume":"7","author":"DM Thappa","year":"2016","unstructured":"Thappa DM, Chiramel MJ. Evolving role of immunotherapy in the treatment of refractory warts. Indian Dermatol Online J. 2016;7(5):364\u201370.","journal-title":"Indian Dermatol Online J"},{"issue":"5","key":"1387_CR25","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/archderm.141.5.589","volume":"141","author":"TD Horn","year":"2005","unstructured":"Horn TD, Johnson SM, Helm RM, Roberson PK. Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: a single-blinded, randomized, and controlled trial. Arch Dermatol. 2005;141(5):589\u201394.","journal-title":"Arch Dermatol"},{"issue":"4","key":"1387_CR26","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1111\/jocd.13718","volume":"20","author":"A Marei","year":"2021","unstructured":"Marei A, Alakad R, Wahid RM. Evaluation of intralesional Candida antigen in diabetic patients with multiple warts. J Cosmet Dermatol. 2021;20(4):1248\u201353.","journal-title":"J Cosmet Dermatol"},{"issue":"10","key":"1387_CR27","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1007\/s00403-023-02698-z","volume":"315","author":"M Fawzy","year":"2023","unstructured":"Fawzy M, Nofal E, Abdelkhalek N, Ehab R. Intralesional bivalent and quadrivalent human papillomavirus vaccines didn\u2019t significantly enhance the response of multiple anogenital warts when co-administered with intralesional Candida antigen immunotherapy. A randomized controlled trial. Arch Dermatol Res. 2023;315(10):2813\u201323.","journal-title":"Arch Dermatol Res"},{"issue":"12","key":"1387_CR28","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1001\/archderm.141.12.1606","volume":"141","author":"M King","year":"2005","unstructured":"King M, Johnson SM, Horn TD. Intralesional immunotherapy for genital warts. Arch Dermatol. 2005;141(12):1606\u20137.","journal-title":"Arch Dermatol"},{"issue":"1","key":"1387_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1634\/theoncologist.6-1-34","volume":"6","author":"E Jonasch","year":"2001","unstructured":"Jonasch E, Haluska FG. Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities. Oncologist. 2001;6(1):34\u201355.","journal-title":"Oncologist"},{"issue":"5","key":"1387_CR30","first-page":"1305","volume":"315","author":"EMK Youssef","year":"2023","unstructured":"Youssef EMK, Eissa MAA, Bakr RM. Intralesional Candida albicans antigen versus intralesional zinc sulfate in treatment of cutaneous warts. Arch Dermatol Res. 2023;315(5):1305\u201314.","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"1387_CR31","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/bjd.13310","volume":"171","author":"JC Sterling","year":"2014","unstructured":"Sterling JC, Gibbs S, Haque Hussain SS, Mohd Mustapa MF, Handfield-Jones SE. British Association of Dermatologists\u2019 guidelines for the management of cutaneous warts 2014. Br J Dermatol. 2014;171(4):696\u2013712.","journal-title":"Br J Dermatol"},{"issue":"6","key":"1387_CR32","first-page":"613","volume":"17","author":"D Abeck","year":"2019","unstructured":"Abeck D, Tetsch L, Luftl M, Biedermann T. Extragenital cutaneous warts-clinical presentation, diagnosis and treatment. J Dtsch Dermatol Ges. 2019;17(6):613\u201334.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"4","key":"1387_CR33","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3121\/cmr.4.4.273","volume":"4","author":"MM Lipke","year":"2006","unstructured":"Lipke MM. An armamentarium of wart treatments. Clin Med Res. 2006;4(4):273\u201393.","journal-title":"Clin Med Res"},{"key":"1387_CR34","doi-asserted-by":"publisher","unstructured":"Kwok CS, Gibbs S, Bennett C, Holland R, Abbott R. Topical treatments for cutaneous warts. Cochrane Database Syst Rev. 2012(9):CD001781. https:\/\/doi.org\/10.1002\/14651858.CD001781.pub3.","DOI":"10.1002\/14651858.CD001781.pub3"},{"issue":"7362","key":"1387_CR35","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1136\/bmj.325.7362.461","volume":"325","author":"S Gibbs","year":"2002","unstructured":"Gibbs S, Harvey I, Sterling J, Stark R. Local treatments for cutaneous warts: systematic review. BMJ. 2002;325(7362):461.","journal-title":"BMJ"},{"issue":"5","key":"1387_CR36","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/ced.12369","volume":"39","author":"CH Na","year":"2014","unstructured":"Na CH, Choi H, Song SH, Kim MS, Shin BS. Two-year experience of using the measles, mumps and rubella vaccine as intralesional immunotherapy for warts. Clin Exp Dermatol. 2014;39(5):583\u20139.","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"1387_CR37","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1111\/jocd.15564","volume":"22","author":"U Lahoria","year":"2023","unstructured":"Lahoria U, Singh S, Bhardwaj A, et al. A prospective randomized controlled study of Mycobacterium indicus pranii vaccine, measles mumps rubella vaccine and vitamin\u00a0D3 in extragenital cutaneous warts. J Cosmet Dermatol. 2023;22(4):1400\u20139.","journal-title":"J Cosmet Dermatol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01387-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-025-01387-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01387-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T17:29:39Z","timestamp":1745688579000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-025-01387-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,29]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1387"],"URL":"https:\/\/doi.org\/10.1007\/s13555-025-01387-1","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"type":"print","value":"2193-8210"},{"type":"electronic","value":"2190-9172"}],"subject":[],"published":{"date-parts":[[2025,3,29]]},"assertion":[{"value":"12 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Stacy R. Smith serves as a clinical study investigator for AbbVie, Alumnis, Amgen, Apollo Therapeutics, Caliway Biopharmaceuticals, Candesant Biomedical, Croma, Eli Lilly, Endo Pharmaceuticals, Evolus, Galderma, Janssen Research and Development, Moberg Pharma, Nielsen Biosciences, Pelage Pharmaceuticals, Pfizer, Q32Bio, Sofregen, Sun Pharmaceuticals, and Teoxane SA; is a consultant for AbbVie, Caliway Biopharmaceuticals, Candesant Biomedical, Eli Lilly, Evolus, Sofregen, and Teoxane SA; and, is a speaker for AbbVie, Eli Lilly, and Janssen Research and Development. H.S. Nielsen Jr. is the Founder, Vice Chairman of the Board of Directors, and employee of Nielsen BioSciences Inc. Robert E. Esch is a member of the Board of Directors of Nielsen BioSciences Inc. Sandra Marchese Johnson is a founder of Type\u00a0IV Technologies; serves as a member of the advisory board for Arcutis; serves as a clinical study investigator for AbbVie, Amgen, Arcutis, BioMetrix, Bristol-Myers Squibb, Cara Therapeutics, Castle Biosciences, Concert Pharmaceuticals, Dermavant Sciences, Evidera Galderma Research and Development, Incyte, Innovaderm Research, Janssen Pharmaceuticals, LEO Laboratories, Lily ICOS, National Psoriasis Foundation, Nielsen BioSciences, Novartis, Regeneron, Sanofi, Takeda Pharmaceuticals, TARGET Pharma, and the University of Pennsylvania; and is a speaker for Amgen, Arkansas College of Osteopathic Medicine, Dermavant Sciences, Galderma, Sanofi, and the University of Arkansas for Medical Sciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was sponsored by Nielsen BioSciences and was conducted in accordance with the ethical principles that have their origin in the Declaration of Helsinki (1964), including the current Seoul revision (2008), and that are consistent with Good Clinical Practice and applicable laws and regulations. The study was reviewed by an institutional review board (IRB), Institutional Review Board Services, on behalf of the study site prior to enrollment of participants. Informed consent was received from all participants prior to the initiation of study-related procedures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}